Pity you were not in a position to buy some more. I'm very happy with the announcement. Have a couple of questions though. 1. How much is each generic likely to make? 2. Have noticed that we have not as yet had any FDA approvals, and is TruPhama going to chase that up? 3. Having signed and agreement for 6 products is a further 3 dossier submissions happening soon. Reading carefully the wording of today's announcement I get the impression that TruPhama will help/ liaise with the FDA, maybe. It's great that TruPhama already have the distribution, sales, marketing, manufacturing and network systems already in place, just means another product is added to the run, keeping cost to a minimum. So need some more announcements with a little more info. Other wise a good day for ACR
Add to My Watchlist
What is My Watchlist?
